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Immunoglobulin heavy chain switch region gene polymorphisms in
glomerutonephritis. Much evidence suggests that primary IgA nephrop-
athy (IgAN) and idiopathic membranous nephropathy (MN) are im-
mune complex mediated diseases. Moreover, genetic factors may play
an important role in their pathogenesis. Recently, restriction fragment
length polymorphisms (RFLPs) of the immunoglobulin heavy chain
genes have been described Which appear to associate with glomerulo-
nephritis. We have studied RFLPs of the switch region of the 1gM (S)
and IgA1 (Sal) heavy chain in MN and IgAN. DNA obtained from
British Caucasoids with IgAN (N = 75), MN (N = 43), and normal
controls (N = 73), was digested with the restriction enzyme Sac I, and
studied using Southern blot techniques and hybridization with a
labelled DNA probe homologous to S. This probe detects RFLPs at
the Ss and Sal loci. The genotypic and allelic frequencies of the Ss and
Sal alleles in IgAN and MN was similar to normal controls. Caucasoid
subjects with IgAN from Northern and Southern Europe (Finland and
Italy, respectively) were also studied to determine whether an ethnic
variation in genetic susceptibility to IgAN exists. The frequency of the
Ss and Sal alleles was similar between the patient groups and their
respective local healthy controls. These results do not support the
recent findings of an association with RFLPs of the Sr and Sal loci in
IgAN and MN, and suggest that the immunoglobulin heavy chain
switch region genes are not important in conferring disease susceptibil-
ity to IgAN or MN.
Primary IgA nephropathy (IgAN) and idiopathic membra-
nous nephropathy (MN) are common causes of primary glomer-
ular disease which may lead to progressive renal impairment
[1—3]. Much evidence suggests that both types of glomerulone-
phritis are immune complex mediated, but their precise immu-
nopathogenesis remains uncertain [3, 4]. However, several
features suggest that disease susceptibility genes may play an
important role.
Familial cases of MN [5] and IgAN [6] have been reported,
and in IgAN, abnormalities of IgA production may be seen not
only in patients but also in unaffected relatives [6]. Family and
population studies have also demonstrated an association with
serologically-defined HLA antigens: HLA-B35 and DR4 in
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IgAN [4, 6] and DR3 (Caucasoids) or DR2 (Japanese) in MN [7,
8]. However, the strength of these associations suggest that
they are not the disease susceptibility genes per se, but that
other gene(s), either within the major histocompatibility com-
plex (MHC) or non-MHC loci, are involved. In addition to the
MHC, genetic control of the immune response may be influ-
enced by immunoglobulin, T cell receptor and complement
genes, and, thus, these loci may be important in determining
disease susceptibility.
Autoimmunity may be a significant feature in the pathogen-
esis of glomerulonephritis [9]. In particular, autoantibodies
have been identified in several types of glomerulonephritis
including IgAN [9—11], and may also be important in MN. The
immunoglobulin genes, therefore, are attractive candidates for
those determining predisposition to glomerulonephritis. Indeed,
protein polymorphisms of the immunoglobulin gamma chain
(Gm allotypes) have been noted to associate with MN [12], and
an increased frequency of a kappa light chain allotype has been
reported in IgAN patients [13].
The advent of recombinant DNA technology now enables
these associations to be examined at the genomic level. In
British Caucasoids we have recently identified a close associa-
tion of IgAN with polymorphisms of the HLA-DQJ3 gene [141,
and failed to find an association of T cell receptor f3 chain
polymorphisms and MN [15]. The genes encoding the immuno-
globulin heavy chains are located on chromosome 14. Each
constant domain gene (except ) is preceded by a switch region
gene which facilitates isotype switching and enables an anti-
body to express different biological properties while retaining
antigen specificity. Thus, the isotypic class of an antibody may
determine its nephritogenic potential. Polymorphisms of the
heavy chain switch region genes may, therefore, be important
in the pathogenesis of glomerulonephritis. Recently, a genomic
DNA probe has been used to examine restriction fragment
length polymorphisms (RFLPs) of the 1gM and IgA1 switch
region genes (S and Sal, respectively) which flank either side
of the IgG constant domain gene which codes for the Gm
allotypes [16]. Preliminary data suggests that polymorphisms of
the switch region genes may indeed be associated with glomer-
ulonephritis [17, 18]. We have, therefore, used Southern blot
analysis and DNA hybridization techniques to examine the
relationship of RFLPs of the immunoglobulin heavy chain
332
Moore et a!: Ig switch region RFLPs in glomeru!onephritis 333
switch region genes to two types of immune-mediated primary
glomerular disease in British Caucasoid subjects: IgAN and
MN. In addition, we have studied Caucasoid subjects with
IgAN from Northern and Southern Europe (Finland and Italy,
respectively), to determine whether an ethnic variation in
genetic susceptibility to IgAN exists.
Methods
Patients and controls
All the subjects studied were unrelated Caucasoids from
Great Britain, Italy, or Finland.
IgAN. Seventy-seven British patients with biopsy-proven
primary IgAN and with no clinical or serological evidence of
Henoch Schönlein purpura, SLE, alcoholic liver disease, or
immunological diseases with recognized associations with
IgAN, were recruited from the Renal Units at The London, St.
Philip's, and St. Thomas' Hospital, London, and the Freeman
Hospital, and Royal Victoria Infirmary, Newcastle. In addition,
DNA was obtained from 73 Italian and 43 Finnish subjects with
primary IgAN from the Renal Units at San Carlo Hospital,
Milan, Italy, and the Tampere University Central Hospital,
Tampere, Finland.
JMN. Blood was collected from 44 British patients with IMN,
who had no clinical, serological, or biochemical evidence of
diseases, infections, or drugs known to be associated with
membranous nephropathy.
Normal controls. Healthy subjects with no history of renal
disease were serially recruited from academic staff and labora-
tory personnel at The London Hospital Medical College (N =
73); San Carlo Hospital (N = 60), and the University of
Tampere (N = 40). Many of the British controls had been
previously studied and reported [191.
DNA analysis
DNA was extracted by a modification of the method of
Kunkel et al from leukocytes obtained from whole blood
samples anticoagulated with EDTA, and previously stored at
—20°C [20]. After digestion for 16 hours, according to the
manufacturer's instructions, with the restriction enzyme Sac 1
(Anglian Biotechnology Ltd, Colchester, England, UK) DNA
fragments were separated by size by electrophoresis on an
0.85% agarose gel and then transferred to a nylon membrane
(Gene Screen Plus; New England Nuclear Research Products,
Boston, Massachusetts, USA) by the method of Southern [21]
using an alkaline solvent [22]. The filters were hybridized to a
nick translated 32P-labelled genomic DNA S probe (see below)
according to standard protocol (New England Nuclear Re-
search Products). All filters were washed down to a high
stringency (0.2 x SSC) and visualized by autoradiography using
Kodak XAR5 film (Eastman Kodak, Rochester, New York) in
the presence of two high-speed intensifying screens for 36 hours
at —70°C. Hybridization bands were sized by comparison with
an internal control (MN genomic DNA) and Hind III digested
lambda phage (Bethesda Research Laboratories, Paisley, Scot-
land, UK) present on each filter. MN genomic DNA allowed
standardization of sizes of alleles between autoradiograms and
also acted as an internal control for the presence of Ss and Sal
alleles.
Fig. 1. Autoradiogram of RFLPs obtained by Sac 1 digestion of DNA
obtained from ten subjects and hybridization with 32P-labelled genomic
S.t probe. Two allelic fragments sized 2.1 kb and 2.6 kb are seen at the
St locus (lane 2). At the Sal locus, two allelic fragments sized 6.9 kb
and 7.4 kb are found (lane 8).
DNA probe
The St probe used was homologous to the Ig St region that
had been cloned into the vector pACYC 184 [23]. The S probe
hybridizes with the immunoglobulin heavy chain switch region
flanking the 1gM constant gene [Cs], and because of sequence
homology also cross hybridizes with the switch region associ-
ated with the IgA1 constant gene [Cal]:S and Sal, respec-
tively.
Statistical methods
The frequency distribution of the S.t and the Sal genotypes
and alleles in the patient and normal control groups was
compared by the Chi-square test using appropriate sized con-
tingency tables, and the Yates' correction.
Results
In conjunction with the restriction enzyme Sac!, the S1z
probe detected two allelic fragments sized 2.1 kb and 2.6 kb at
the S locus giving the genotypes: 2.1/2.1 kb, 2.1/2.6 kb, or
2.6/2.6 kb. At the Sal locus, two allelic fragments sized 6.9 kb
and 7.4 kb were detected giving the genotypes: 6.9/6.9 kb,
6.9/7.4 kb, or 7.4/7.4 (Fig. 1).
The genotypic frequency of the S and Sal alleles in British
Caucasoid subjects is given in Table 1. The genotypic distribu-
tion of the S and Sal loci was similar in British normal
controls and patients with IgAN or MN. Similarly, the geno-
typic and allelic frequency of the S and Sal alleles in Finnish
and Italian patients with IgAN was comparable to that found in
healthy Finnish and Italian controls, respectively (Table 2).
The frequency distribution of the S and Sal alleles was
compared between the healthy control groups. The distribution
of the S genotypes was similar in British, Finnish, and Italian
normal controls (Tables I and 2). However, there was an
increased frequency of the 7.4 kb homozygous Sal genotype in
Italian controls [61 .8%J compared to Finnish controls (35.0%, P
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Table 1. British
and Sal
Caucasoids; Genotypic and allelic frequency of Ss
alleles in normal controls, IgAN and MN
Group N Locus
Controls
IgAN
MN
73
75
43
Genotypic frequencya Allelic
frequency
Sukb
2.1 2,1/2.6 2.6 2.1 2.6
l37 53.4 32.9 0.40 0.60
25.3 54.7 20.0 0.53 0.47
23.3 48.8 27.9 0.52 0.48
Controls
IgAN
MN
69
66
44
Sal kb
6.9 6.9/7.4 7.4 6.9 7.4
15.9 40.6 43.5 0.36 0.64
13.7 43.9 42.4 0.36 0.64
6.8 50.0 43.2 0.32 0.68
Abbreviations are: IgAN, patients with IgA nephropathy; MN,
patients with membranous nephropathy.
a Data are expressed as percentb Comparison of S and Sal genotypic and allelic frequencies is, by
chi square analysis, not significant.
Table 2. Italian and Finnish Caucasoids; Genotypic and allelic
frequency of S and Sal alleles in normal controls and IgAN
Group N Locus
Genotypic frequencya Allelic
frequency
Finnish
S kb
2.6 2.1 2.62.1 2.1/2.6
IgAN 43 163b 53.5 30.2 0.43 0.57
Controls 39 20.5 59.0 20.5 0.50 0.50
Italian
IgAN 73 24.7 50.6 24.7 0.50 0.50
Controls 60 16.7 56.6 26.7 0.45 0.45
Finnish
Sal kb
7.4 6.9 7.46.9 6.9/7.4
IgAN 40 15.0 57.5 27.5 0.44 0.56
Controls 40 12.5 52.5 35,0 0,39 0.61
Italian
IgAN 73 6.8 37.0 56.2 0.25 0.75
Controls 55 7,3C 30.9 61.8 0.23 0.77
a Data are expressed as percentb Comparison of distribution of S and Sal allelic and genotypic
frequencies between patient and normal control groups: not significant
Sal genotypic frequency, Italian vs. Finnish controls, P = 0.036 2
= 6.63, Cramer's V = 0.26.
= 0.036, 6.63], but not to British Controls (43.5%). The
Sal allelic frequency was similar between the three normal
control populations.
To determine whether RFLPs of the Sjs of Sal loci were
markers for mode of clinical presentation or renal impairment
Table 3. British Caucasoids; Genotypic frequency of S1 and
alleles in IgAN and MN according to clinical features
Sal
Clinical S kb Sal kb
features N 2.1 2.1/2.6 2.6 N 6.9 6.9/7.4 7.4
IgAN
Cr < l25 46 261b 54.3 19.6 39 2.6C 51.3 46.1Cr  125 28 25.0 53.6 21.4 25 28.0 40.0 32.0
MacroH 18 27.8 66.7 5.6 15 6.7 53.3 40.0
No MacroH 59 25.4 50.8 23.7 52 15.4 44.2 40.4
MN
Cr < 125 22 18.2 50.0 31.8 22 9.1 50.0 40.9
Cr 125 21 14.3 47.6 38.1 22 4.5 50.0 45.4
a Serum creatinine < or  125 Mmol/liter at time of study
b Data expressed as percent
C Sal genotypic frequency, IgAN patients with creatinine < or  125
smo1J1iter; P = 0.043, = 6.3d Patients presenting with or without episodes of macroscopic hema-
tuna; no significant different in genotypic distribution between groups
the patients were divided into subgroups: IgAN and MN, 1)
serum creatinine <125 mol/1iter at time of blood sampling, or
2) serum creatinine 125 mol/liter; and IgAN only, 1) clinical
presentation either with episodes of macroscopit hematuria, or
2) with microscopic hematuna and! or proteinuria but no
macroscopic hematuria. Fourty-nine percent of British patients
with MN had an elevated serum creatinine at the time of study.
The incidence of renal impairment in patients with IgAN varied
between the ethnic groups: Britain 35.2%, Italy 27.0%, Finland
16.0%, P = 0.043, = 6.3. In British IgAN patients, although
the 6.9 kb homozygous Sal genotype was associated with renal
impairment by conventional levels of statistical significance
(Table 3), the absolute number of subjects is small (N = 8), and
there is no significant association when a creatinine of 150
molJliter is chosen as the discriminating value. Furthermore,
the allelic and genotypic frequency of the S and Sal loci was
similar between Italian or Finnish IgAN patients with or with-
out renal impairment. Clinical presentation with episodes of
macroscopic hematuria were more common in Italian IgAN
patients (55.4%, P 0.0001, = 34.0) than in British (23.4%)
or Finnish (16.0%) patients with IgAN. There was no associa-
tion of RFLPs of S of Sal with macroscopic hematuna
(British data, Table 3; Finnish and Italian data on request).
Discussion
The principal finding to emerge from this study was the
absence of any association of RFLPs of the immunoglobulin
heavy chain switch region genes, St and Sal, in British
Caucasoid subjects with either IgAN or MN, and in two other
groups of Caucasoid subjects with IgAN from different ethnic
origins. These results confirm the previous reports of either no
association, or only a weak association of IgAN [13] and MN
[12] with Gm allotypes. However, they are in contrast to the
findings of Demaine and colleagues who have noted a decreased
frequency or the 2.1/2.6 kb S heterozygote genotype in both
types of glomerulonephritis [17, 18], and an increased fre-
quency of the 7.4 kb homozygous Sal genotype, and in
particular an increase in the 7.4 kb allele, in IgAN [18].
There are several possible explanations for these discrepan-
cies with our observations. First, the strength of the associa-
tions reported by Demaine et al are low, and in both studies a
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smaller group of subjects have been studied. Second, in their
study, the ethnic origin of the patient and control groups of
subjects is not stated, but it appears that study groups of mixed
ethnicity may have been examined. The genotype distribution
of the S and Sal alleles in their control group are very similar
to that seen in our healthy British control subjects, but differ-
ences in the Sal genotypic frequency between the two respec-
tive IgAN patient populations exist. If the IgAN patient group
in the study of Demaine et al is composed of a mixture of British
and German Caucasoids, then ethnic genetic variation may
account for the observed differences. The latter argument is
supported by our observation of differences in the Sal geno-
typic distribution between the healthy control groups of distinct
ethnic origin. Further support is provided by a study of the
HLA-DR distribution in 22 distinct Caucasoid populations
reported at the VIII HLA International Histocompatibility
Workshop; significant differences were observed between Brit-
ish and German Caucasoids [241, thus, emphasizing the impor-
tance of ensuring ethnic homogeneity in such studies. Third,
technical reasons are unlikely to be the explanation; we have
used the same probe and restriction enzyme combination, and,
furthermore, many of the results obtained in the British normal
control group have been duplicated between our respective
laboratories [19]. Finally, the majority of IgAN patients studied
by Demaine et al were young males who presented with
macroscopic hematuria, and all had normal renal function. It
has been suggested that IgAN is two disease subentities [25],
and thus, differences in the clinical composition between our
and Demaine and colleagues study groups may explain the
observed discrepancies. It is interesting to note that, probably
as a result of different biopsy policies, the three groups of
patients with IgAN from Britain, Finland, and Italy varied with
respect to the proportion of subjects with renal impairment or
presenting with macroscopic hematuria. Nevertheless, we were
unable to demonstrate a consistent association with Sr or Sal
alleles in the subgroups of IgAN patients derived from the three
ethnic populations with different clinical features. Therefore, an
ethnic variation in genetic susceptibility to IgAN is unlikely to
be mediated by polymorphisms of the immunoglobulin heavy
chain switch region genes.
It has been suggested that genetic factors may not only
determine susceptibility to glomerulonephritis, but may also
influence the natural course of the disease [26, 27]. In particu-
lar, an association with Gm allotypes, and with K light chain
allotypes, has been reported in the subgroup of patients with
chronic renal failure in MN [12], and IgAN [13], respectively. In
addition, episodes of macroscopic hematuria have been linked
to a Gm allotype [25]. However, we were unable to find an
association of the S or Sal genes with either mode of clinical
presentation in IgAN, or the development of renal impairment.
Our results suggest that the switch region genes do not influence
the clinical expression of glomerulonephritis.
Several features suggest that disease susceptibility genes may
be important in the pathogenesis of IgAN and MN [3, 6]. In
addition, a body of evidence indicates that autoimmunity plays
a role in glomerulonephritis [9]. Indeed, in IgAN autoantibodies
to glomerular and non-glomerular structures have been identi-
fied [10, 28—31]. The immunoglobulin genes have, thus, at-
tracted attention as putative genes involved in determining
predisposition to glomerulonephritis. In particular, the switch
region genes are likely candidates; they enable B cells to
express a preserved variable (V), diversity (D), and joining (J)
segment gene complex with different constant domain genes
and thus 'switch' isotypes. Therefore, antibodies with a defined
antigen specificity may exhibit different biological characteris-
tics, such as ability to fix complement, Fc receptor binding, and
electrical charge, which may be important in determining the
nephritogenic potential of antibodies. However, our results do
not support this hypothesis. Moreover, examination of switch
region gene polymorphisms in other, autoimmune diseases has
produced only a weak or absent association [19, 32]. Neverthe-
less, our results do not exclude the possibility that other
immunoglobulin genes may be involved. Alternative candidate
genes are the heavy chain variable genes, or the genes control-
ling the diversity and joining segments. Polymorphisms of these
genes could lead to restriction of the antigen recognition reper-
toire of antibodies, and therefore could be important in the
autoimmune response. Indeed, antibodies with restriction of
idiotypes have been reported in IgAN [33] and other types of
glomerulonephritis [9, 34].
In conclusion, we have been unable to demonstrate an
association of RFLPs of the immunoglobulin heavy chain
switch region genes in three distinct Caucasoid ethnic groups
with immune complex-mediated glomerulonephritis, IgAN and
MN. Further work is needed to examine the putative role of
variable region genes on the pathogenesis of glomerulonephri-
tis.
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